BMJ Oncology

Title Publication Date Language Citations
Identifying the deficits in cancer care for people with intellectual disabilities2024/02/01English
Accuracy of screening tests for cervical precancer in women living with HIV in low-resource settings: a paired prospective study in Lusaka, Zambia2024/02/01English
Guilty by association? The complex relationship between immunosuppressants and cancer2023/08/01English
Can PSA testing become appropriate public health policy?2023/08/01English
Uncovering the role of mismatch repair deficiency and microsatellite instability in urothelial carcinoma2024/04/01English
Mismatch repair deficiency and microsatellite instability in urothelial carcinoma: a systematic review and meta-analysis2024/04/01English
Shifting tides: the rising tide of early-onset cancers demands attention2023/07/01English
Making administrative healthcare systems clinical data the future of clinical trials: lessons from BladderPath2023/07/01English
Welcome toBMJ Oncology2022/10/01English
Time, location and function of hypoxia-inducible factors are critical to therapeutic tumour response2024/02/01English
Time to treat the climate and nature crisis as one indivisible global health emergency2023/10/01English
Machine learning predicted fast progression after initiation of immune checkpoint inhibitors in advanced non-small cell lung cancer2024/02/01English
Closing the gaps in recruitment and retention in cancer trials: sufficient evidence but poor implementation2023/11/01English
PACT-UK (PAncreatic Cancer reporting Template–UK): a cross-specialty multi-institutional consensus panel development of a standardised radiological reporting proforma for pancreatic cancer2023/11/01English
Boosting and broadening recruitment to UK cancer trials: towards a blueprint for action2023/11/01English
Another piece in the overdiagnosis jigsaw puzzle2023/12/01English
Endpoints for trials of adjuvant anticancer therapies2023/12/01English
Multi-cancer early detection tests: a strategy for improvement2024/01/01English
Pharmacological class effects of anticancer drugs: opportunities for decreasing healthcare spending2024/01/01English
Comparison of standard-dose and reduced-dose treatment of metastatic prostate cancer with enzalutamide, apalutamide or darolutamide: a rapid review2024/02/01English
Updating the NHS cancer waiting time standards2024/03/01English
HealthCare Access Barrier (HCAB) framework for the barriers to cancer care during conflicts: perspective from Iraq2024/03/01English
Tale of two zones: investigating the clinical outcomes and research gaps in peripheral and transition zone prostate cancer through a systematic review and meta-analysis2024/04/01English
Characterisation of clinical response and transcriptional profiling of proliferating CD8 T cells in the blood of cancer patients after PD-1 monotherapy or combination therapy2024/04/01English
Postprogression therapy and confounding for the estimated treatment effect on overall survival in phase III oncology trials2024/04/01English
Predictive biomarkers and specific immune responses of COVID-19 mRNA vaccine in patients with cancer: prospective results from the CACOV-VAC trial2023/12/01English
Artificial intelligence across oncology specialties: current applications and emerging tools2024/01/01English
Repurposing radiosensitising medicines for radiotherapy: an overview2024/01/01English
Embracing rapid learning in radiotherapy: feasible and acceptable with stakeholder corroboration2024/03/01English
Assessing patient risk, benefit and outcomes in drug development: an observational study of regorafenib clinical trials2024/03/01English